The report highlights all important opportunities for the generic companies based on the latest patent litigation updates. The analyses provides an insight into each product opportunity for generic companies in terms of
likely timeline of the first generic launch in US
potential competition on the first day of launch and
companies likely to benefit in case of a probable launch under low competition
